Earnings
Arista's Revenue Jumps 58.5% To $3.66 Billion, Topping Its Own $3.3 Billion Guidance
The networking company forecast fourth-quarter revenue of $3.9 billion to $4.0 billion, above the quarter it just reported.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
The networking company forecast fourth-quarter revenue of $3.9 billion to $4.0 billion, above the quarter it just reported.
Deals
The Denver shale producer redeemed $417 million of notes and returned $133 million to holders while narrowing its capital budget to about $2.75 billion.
Earnings
The consulting firm lifted its 2026 adjusted EPS midpoint to $9.30 and raised its buyback authorization to $1.1 billion.
Earnings
The medical device contract maker's CEO said program transfers and margin improvement remain behind plan despite an 11.6% sales gain.
Earnings
Third-quarter net income rose to $169 million from $105 million, and Elena Gomez will hand the CFO job to Michael Senno on January 1, 2027.
SEC Filings
Block raised its 2026 outlook, and Cash App reached 60 million monthly transacting actives in September.
Deals
Latin America acquisitions drove the sales gain, while adjusted EBITDA margin slipped to 39.0% from 40.5% a year earlier.
Markets
The can maker posted a $94 million quarterly loss on a pension charge, while adjusted earnings per share rose and its 2026 targets held.
SEC Filings
Joseph Edelman's fund manager now holds 3.9% of Nautilus Biotechnology after open-market sales that ran from July 28 to October 26.
Insider Trades
Norwitt bought the shares at $11.1863 through options and sold them at an average $82.48, keeping 5,391,304 shares.
SEC Filings
The cancer drugmaker will lean on published Phase 2 data for guideline inclusion instead of a registrational trial of neoadjuvant darovasertib.
Earnings
PayPay's adjusted EBITDA margin reached 36% and beat guidance, while profit fell 75% against a prior-year tax benefit.